Givaudan Strikes Deal For Amyris Ingredients, Long-Term Partnership
Executive Summary
The deal has Amyris selling three key cosmetic ingredients to Givaudan and producing more biotech ingredients for the Swiss firm over the long term. “In the future, we will continue to push the boundaries of biotech, creating new sustainable innovations for a better beauty future,” says Givaudan’s Maurizio Volpi, president, Fragrance and Beauty.
You may also be interested in...
Firmenich, IFF Tout Eco-Fragrance Design Tools; Inter Parfums’ Sales Soar In Q4; Fragrance Sales & Sustainability News
Firmenich and International Flavors & Fragrances’ LRM Naturals announce developments to better support customers’ sustainable product development and transparency needs. Givaudan, Symrise and Inter Parfums report strong results in fiscal 2022, fueled by unleashed fragrance demand around the globe.
Biotech Amyris: ‘We Have Built The Fastest-Growing Consumer Business In Health, Beauty And Wellness’
Emeryville, CA-based Amyris launches the Stripes menopause care line with actress Naomi Watts, as well as Gen Z-targeted EcoFabulous skin care and cosmetics, acquired last year. The biotech projects its burgeoning Consumer business will grow more than 150% in 2022.
Biotech Amyris Targeting 150% Consumer Biz Growth In 2022, Up To 40% In Ingredients Arm
The Emeryville, CA-based synthetic biotech firm projects big growth in 2022 as customers seek out “the purest, cleanest and most sustainably sourced natural ingredients in the world.” Amyris’ business is split between Technology Access and Consumer, the latter set to more than double this year.